VSD: Assessment & Diagnosis


"Prenatal screening programmes typically recommend detailed assessment of fetuses judged to be at high risk of congenital heart disease. However, most cases of congenital heart disease arise in the low-risk population, and detection of affected fetuses in this setting depends on recognizing abnormalities of the heart during the midtrimester scan (Hunter, 2014)".

Current recommendations focus on screening newborns for CHD in the well-baby nursery and in intermediate care nurseries or other units in which discharge from the hospital is common during a newborn’s first week of life. Timing the screening around the time of the newborn hearing screening can help improve efficiency. A pulse oximeter is used to measure the percentage of hemoglobin in the blood that is saturated with oxygen (CDC, 2022).

Ventricular septal defect is often not diagnosed before 4 to 8 weeks of age. Prior to this age the lung's alveoli are not completely opened. As a result, there is high pulmonary artery resistance. This resistance limits the amount blood shunted through the defect.

As lungs develop, pulmonary circulation expands and pulmonary resistance decreases. When pulmonary resistance falls below the pressure generated by the left ventricle, blood will flow across the vsd toward the area of lower pressure.

If a child shows signs of congestive heart failure, further assessments are made. Findings that suggest VSD include:


Instant Feedback:
Ventricular septal defects are commonly diagnosed in the first few days of the neonate's life.

True
False

With VSD, the oxygen saturation level may be higher than normal in the right ventricle.

True
False

References

CDC, (2022). Congenital Heart Defects Information for Healthcare Providers. Accessed April 25, 2022 from: https://www.cdc.gov/ncbddd/heartdefects/hcp.html

Hunter, L. E., & Simpson, J. M. (2014). Prenatal screening for structural congenital heart disease. Nature reviews. Cardiology, 11(6), 323–334. https://doi.org/10.1038/nrcardio.2014.34

Kemper AR, Mahle WT, Martin GR, Cooley WC, Kumar P, Morrow WR, Kelm K, Pearson GD, Glidewell J, Grosse SD, Lloyd-Puryear M, Howell RR. Strategies for implementing screening for critical congenital heart disease. Pediatrics. 2011; 128:e1-8 (Graphic from https://www.cdc.gov/ncbddd/heartdefects/hcp.html)